Requirement of Heterogeneous Nuclear Ribonucleoprotein C for BRCA Gene Expression and Homologous Recombination

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Anantha, Rachel W ^a   Alcivar, Allen L ^a   Ma, Jianglin ^a   Cai, Hong ^a   Simhadri, Srilatha ^a   Ule, Jernej ^b   König, Julian ^b   Xia, Bing ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; MESSENGER RNA; NUCLEAR PROTEIN; PEPTIDES AND PROTEINS; PROTEIN BRIP1; PROTEIN PALB2; RAD51 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; HOMOLOGOUS RECOMBINATION; IMMUNOFLUORESCENCE; IONIZING RADIATION; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; S PHASE CELL CYCLE CHECKPOINT; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP C; HOMOLOGOUS RECOMBINATION; HUMANS; NUCLEAR PROTEINS; PROTEIN BINDING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84876021588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061368     Document Type: Article

References (44)

1. Beyer AL, Christensen ME, Walker BW, LeStourgeon WM, (1977) Identification and characterization of the packaging proteins of core 40S hnRNP particles. Cell 11: 127-138.
2. Huang M, Rech JE, Northington SJ, Flicker PF, Mayeda A, et al. (1994) The C-protein tetramer binds 230 to 240 nucleotides of pre-mRNA and nucleates the assembly of 40S heterogeneous nuclear ribonucleoprotein particles. Mol Cell Biol 14: 518-533.
3. Gorlach M, Burd CG, Dreyfuss G, (1994) The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins. J Biol Chem 269: 23074-23078.
4. Soltaninassab SR, McAfee JG, Shahied-Milam L, LeStourgeon WM, (1998) Oligonucleotide binding specificities of the hnRNP C protein tetramer. Nucleic Acids Res 26: 3410-3417.
5. McAfee JG, Soltaninassab SR, Lindsay ME, LeStourgeon WM, (1996) Proteins C1 and C2 of heterogeneous nuclear ribonucleoprotein complexes bind RNA in a highly cooperative fashion: support for their contiguous deposition on pre-mRNA during transcription. Biochemistry 35: 1212-1222.
6. Swanson MS, Dreyfuss G, (1988) Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol Cell Biol 8: 2237-2241.
7. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, et al. (2010) iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol 17: 909-915.
8. Zarnack K, Konig J, Tajnik M, Martincorena I, Eustermann S, et al. (2013) Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu Elements. Cell 152: 453-466.
9. Williamson DJ, Banik-Maiti S, DeGregori J, Ruley HE, (2000) hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. Mol Cell Biol 20: 4094-4105.
10. Kass EM, Jasin M, (2010) Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett 584: 3703-3708.
11. Moynahan ME, Jasin M, (2010) Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 11: 196-207.
12. Roy R, Chun J, Powell SN, (2011) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nature reviews Cancer 12: 68-78.
13. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, et al. (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22: 719-729.
14. Tischkowitz M, Xia B, (2010) PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res 70: 7353-7359.
15. Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, et al. (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America 108: 18032-18037.
16. Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, et al. (2011) Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer research 71: 2222-2229.
17. Sy SM, Huen MS, Chen J, (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proceedings of the National Academy of Sciences of the United States of America 106: 7155-7160.
18. Zhang F, Ma J, Wu J, Ye L, Cai H, et al. (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Current biology: CB 19: 524-529.
19. Zhang F, Fan Q, Ren K, Andreassen PR, (2009) PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol Cancer Res 7: 1110-1118.
20. Yun MH, Hiom K, (2009) CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 459: 460-463.
21. Chen L, Nievera CJ, Lee AY, Wu X, (2008) Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J Biol Chem 283: 7713-7720.
22. Huertas P, Jackson SP, (2009) Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem 284: 9558-9565.
23. Bunting SF, Callen E, Wong N, Chen HT, Polato F, et al. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141: 243-254.
24. Holloman WK, (2011) Unraveling the mechanism of BRCA2 in homologous recombination. Nature structural & molecular biology 18: 748-754.
25. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, et al. (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39: 159-161.
26. Dray E, Etchin J, Wiese C, Saro D, Williams GJ, et al. (2010) Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2. Nature structural & molecular biology 17: 1255-1259.
27. Buisson R, Dion-Cote AM, Coulombe Y, Launay H, Cai H, et al. (2010) Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nature structural & molecular biology 17: 1247-1254.
28. Sy SM, Huen MS, Chen J, (2009) MRG15 is a novel PALB2-interacting factor involved in homologous recombination. J Biol Chem 284: 21127-21131.
29. Hayakawa T, Zhang F, Hayakawa N, Ohtani Y, Shinmyozu K, et al. (2010) MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. J Cell Sci 123: 1124-1130.
30. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, et al. (2005) Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci U S A 102: 1110-1115.
31. Gunn A, Stark JM, (2012) I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks. Methods Mol Biol 920: 379-391.
32. Menzel T, Nahse-Kumpf V, Kousholt AN, Klein DK, Lund-Andersen C, et al. (2011) A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance. EMBO Rep 12: 705-712.
33. Zou L, Elledge SJ, (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300: 1542-1548.
34. San Filippo J, Sung P, Klein H, (2008) Mechanism of eukaryotic homologous recombination. Annu Rev Biochem 77: 229-257.
35. Stark JM, Pierce AJ, Oh J, Pastink A, Jasin M, (2004) Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol 24: 9305-9316.
36. Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, et al. (2007) Human CtIP promotes DNA end resection. Nature 450: 509-514.
37. Adamson B, Smogorzewska A, Sigoillot FD, King RW, Elledge SJ, (2012) A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nature cell biology 14: 318-328.
38. Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, et al. (2003) Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Molecular and Cellular Biology 23: 3774-3787.
39. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, et al. (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810.
40. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, et al. (1996) The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023.
41. Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A, (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11: 1226-1241.
42. Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, et al. (1996) Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proceedings of the National Academy of Sciences of the United States of America 93: 6236-6240.
43. Hossain MN, Fuji M, Miki K, Endoh M, Ayusawa D, (2007) Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa cells to various stresses. Mol Cell Biochem 296: 151-157.
44. Saleh-Gohari N, Bryant HE, Schultz N, Parker KM, Cassel TN, et al. (2005) Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks. Mol Cell Biol 25: 7158-7169.